New brain vessel blocking treatment enters trial
Disease control
Recruiting now
This study is testing a new liquid embolic agent to see if it works as well as an existing treatment for brain arteriovenous malformations (AVMs). About 116 adults with specific types of brain AVMs will be enrolled. The goal is to see if the new agent can safely and effectively b…
Phase: NA • Sponsor: MicroPort NeuroTech Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC